IP Library Granted Patent US 10,271,995
Granted Patent B2
US 10,271,995 · App. 14/653,760 · Granted Apr 30, 2019

Wound dressing with adhesive margin

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,271,995
App. No.
14/653,760
Granted
Apr 30, 2019
Kind
B2
Abstract

A wound dressing comprising: a backing sheet; a layer of pressure-sensitive adhesive on the backing sheet; an island of absorbent material having smaller area than the backing sheet and applied onto a central region of the backing sheet so as to leave a margin of adhesive-coated backing sheet around the absorbent material, and an apertured wound facing layer applied over the absorbent material and adhered to the backing sheet around said island by said pressure-sensitive adhesive, wherein the apertured wound facing layer comprises an apertured substrate having a coating of a silicone gel on the wound facing surface thereof, the open area of the apertured wound facing layer is from about 5% to about 75%, and the apertured wound facing layer comprises apertures having an open area of from about 2 mm2 to about 100 mm 2 .

Claims (18)

1. A wound dressing comprising:

a backing sheet;

a pressure-sensitive adhesive;

an island of absorbent material on a central region of the backing sheet, wherein the island has a smaller area than the backing sheet and has a first backing-facing side and a second wound-facing side, and wherein the pressure-sensitive adhesive is on at least part of the backing sheet including an area around the island; and

an apertured wound-facing layer over the second wound-facing side of the island, wherein said apertured wound-facing layer extends beyond the island and is adhered to the backing sheet around said island by said pressure-sensitive adhesive;

wherein the apertured wound-facing layer comprises an apertured substrate having a coating of a silicone elastomer on a wound-facing surface thereof, an open area of the apertured wound-facing layer is from about 5% to about 75% of the apertured wound-facing layer, and the apertured wound-facing layer is configured to allow a portion of the pressure-sensitive adhesive through the apertured wound-facing layer to contact a user's skin when the wound dressing is applied to the user;

wherein the apertured wound-facing layer comprises a line or lines of weakness substantially parallel to, and spaced from, one or more edges of the apertured wound-facing layer defining a tear-off strip or strips along one or more edges of the apertured wound-facing layer.

2. The wound dressing according to claim 1 , wherein the apertured wound-facing layer comprises apertures of which at least about 90% have an open area of from about 5 mm 2 to about 50 mm 2 .

3. The wound dressing according to claim 1 , wherein said apertures consist essentially of a regular array of apertures, and wherein at least 90% of the apertures have an open area of from about 2 mm 2 to about 100 mm 2 .

4. The wound dressing according to claim 1 , wherein a thickness of the apertured wound-facing layer is less than about 1 mm.

5. The wound dressing according to claim 1 , wherein the apertured substrate is an apertured film.

6. The wound dressing according to claim 1 , wherein the apertured wound-facing layer is smaller than the backing sheet.

7. The wound dressing according to claim 6 , wherein a first margin of the backing sheet having the apertured layer has a mean width of from about 5 mm to about 30 mm, and a second margin of the backing sheet has a mean width of from about 2 mm to about 20 mm.

8. The wound dressing according to claim 1 , wherein a pull tab is attached to, or formed integrally with, each of the tear-off strip or strips to assist removal of the tear-off strip or strips.

9. The wound dressing according to claim 1 , wherein the silicone elastomer is a hydrophobic, tacky or non-tacky silicone polymer.

10. The wound dressing according to claim 1 , wherein a thickness of the apertured wound-facing layer is from about 0.02 mm to about 0.5 mm.

11. The wound dressing according to claim 1 , wherein the silicone elastomer is weakly adherent in comparison to the pressure-sensitive adhesive.

12. The wound dressing according to claim 1 , wherein the silicone elastomer is non-adherent.

Assignments (10)
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Nov 7, 2019
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: KCI USA, INC.; KCI LICENSING, INC.
Reel/Frame 050966/0547 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Nov 6, 2019
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: KINETIC CONCEPTS, INC.; KCI USA, INC.; ACELITY L.P. INC.; CHIRON HOLDINGS, INC.; CHIRON TOPCO, INC.; KCI ANIMAL HEALTH, LLC; KCI HOLDING COMPANY, INC.; KCI HOMECARE, INC.; KCI IMPORTS, INC.; KCI INTERNATIONAL, INC.; KCI LICENSING, INC.; KCI PROPERTIES LIMITED; KCI REAL HOLDINGS, L.L.C.; KCI REAL PROPERTY LIMITED; KCI USA REAL HOLDINGS, L.L.C.; TECHNIMOTION, LLC
Reel/Frame 050945/0278 →
RELEASE OF SECURITY INTEREST Recorded Oct 11, 2019
From: BANK OF AMERICA, N.A.
To: KCI USA, INC.
Reel/Frame 050710/0955 →
RELEASE OF SECURITY INTEREST REEL/FRAME 040098/0268 Recorded Feb 8, 2017
From: WILMINGTON TRUST
To: KCI USA, INC.
Reel/Frame 041666/0320 →
SECURITY AGREEMENT Recorded Feb 7, 2017
From: KCI USA, INC., AS GRANTOR
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 041650/0013 →
LIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Oct 7, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040291/0237 →
SECOND LIEN SECURITY AGREEMENT Recorded Sep 21, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040098/0268 →
SECURITY INTEREST Recorded Feb 17, 2016
From: KINETIC CONCEPTS, INC.; KCI USA, INC.; ACELITY L.P. INC.; CHIRON HOLDINGS, INC.; CHIRON TOPCO, INC.; KCI ANIMAL HEALTH, LLC; KCI HOLDING COMPANY, INC.; KCI HOMECARE, INC.; KCI IMPORTS, INC.; KCI INTERNATIONAL, INC.; KCI LICENSING, INC.; KCI PROPERTIES LIMITED; KCI REAL HOLDINGS, L.L.C.; KCI REAL PROPERTY LIMITED; KCI USA REAL HOLDINGS, L.L.C.; LIFECELL CORPORATION; TECHNIMOTION, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 037845/0497 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 23, 2015
From: SYSTAGENIX WOUND MANAGEMENT IP CO. B.V.
To: KCI USA, INC.
Reel/Frame 036636/0413 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 23, 2015
From: PIGG, WILLIAM; DELBONO, MICHELLE; STEPHENS, SALLY
To: KCI USA, INC.
Reel/Frame 036636/0541 →
Cited By (2)
US 1,076,109 US 1,104,272